208 related articles for article (PubMed ID: 2935958)
1. Cancer chemotherapeutics as immunomodulators.
Spreafico F; Vecchi A; Colotta F; Montovani A
Springer Semin Immunopathol; 1985; 8(4):361-74. PubMed ID: 2935958
[No Abstract] [Full Text] [Related]
2. Immunomodulation by cancer chemotherapeutic agents and antineoplastic activity.
Spreafico F; Mantovani A
Pathobiol Annu; 1981; 11():177-95. PubMed ID: 6460217
[No Abstract] [Full Text] [Related]
3. The heterogeneity of the interaction between cancer chemotherapeutic agents and host resistance mechanisms.
Spreafico F
Recent Results Cancer Res; 1980; 75():200-6. PubMed ID: 6453410
[TBL] [Abstract][Full Text] [Related]
4. Tumor induced immunosuppression.
Roth JA
Surg Gynecol Obstet; 1983 Feb; 156(2):233-40. PubMed ID: 6186039
[No Abstract] [Full Text] [Related]
5. The effect of cytostatic therapy on cellular immunity in vitro.
Winnewisser M; Theml H; Begemann H
Recent Results Cancer Res; 1975; (52):107-13. PubMed ID: 1087741
[No Abstract] [Full Text] [Related]
6. Third annual Sapporo Cancer Seminar. Biological responses in cancer chemotherapy.
Cancer Res; 1983 Dec; 43(12 Pt 1):6109-12. PubMed ID: 6227384
[No Abstract] [Full Text] [Related]
7. Update on anaesthesia and the immune response.
Moudgil GC
Can Anaesth Soc J; 1986 May; 33(3 Pt 2):S54-60. PubMed ID: 2941118
[No Abstract] [Full Text] [Related]
8. [Use of immunological methods in the oncological clinic].
Trapeznikov NN; Kadagidze ZG
Vestn Akad Med Nauk SSSR; 1982; (12):66-70. PubMed ID: 6218706
[No Abstract] [Full Text] [Related]
9. Antitumoral and other biomedical activities of synthetic ether lysophospholipids.
Munder PG; Westphal O
Chem Immunol; 1990; 49():206-35. PubMed ID: 2190582
[No Abstract] [Full Text] [Related]
10. Old cancer drug gets fresh look.
Ledford H
Nature; 2014 May; 509(7502):541-2. PubMed ID: 24870520
[No Abstract] [Full Text] [Related]
11. Chemical-induced immunomodulation.
Koller LD
J Am Vet Med Assoc; 1982 Nov; 181(10):1102-6. PubMed ID: 6816774
[No Abstract] [Full Text] [Related]
12. TLR ligand suppression or enhancement of Treg cells? A double-edged sword in immunity to tumours.
Conroy H; Marshall NA; Mills KH
Oncogene; 2008 Jan; 27(2):168-80. PubMed ID: 18176598
[TBL] [Abstract][Full Text] [Related]
13. Tumor infiltrating regulatory T cells: tractable targets for immunotherapy.
Khan AR; Dovedi SJ; Wilkinson RW; Pritchard DI
Int Rev Immunol; 2010 Oct; 29(5):461-84. PubMed ID: 20839911
[TBL] [Abstract][Full Text] [Related]
14. Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine.
Ohshio Y; Teramoto K; Hanaoka J; Tezuka N; Itoh Y; Asai T; Daigo Y; Ogasawara K
Cancer Sci; 2015 Feb; 106(2):134-42. PubMed ID: 25483888
[TBL] [Abstract][Full Text] [Related]
15. T-regulatory cell response in psoriasis and changes with imatinib therapy.
Thachil J
Clin Exp Dermatol; 2009 Dec; 34(8):e1022. PubMed ID: 20055827
[No Abstract] [Full Text] [Related]
16. [Immunity in cases of neoplasms treated with cytostatic drugs].
Lotreanu V; Sarafoleanu D
Rev Chir Oncol Radiol O R L Oftalmol Stomatol Otorinolaringol; 1981; 26(1):59-60. PubMed ID: 6454220
[No Abstract] [Full Text] [Related]
17. Effects of combination chemotherapy on immunoregulatory cells in peripheral blood of solid tumor cancer patients: correlation with rebound overshoot immune function recovery.
Braun DP; Harris JE
Clin Immunol Immunopathol; 1981 Aug; 20(2):193-214. PubMed ID: 6455230
[No Abstract] [Full Text] [Related]
18. On the immunopharmacology of cancer chemotherapeutics.
Spreafico F
Behring Inst Mitt; 1984 May; (74):230-8. PubMed ID: 6541034
[TBL] [Abstract][Full Text] [Related]
19. [Characteristics of suppressor cells associated with antitumor immunity and their elimination leading to enhancement of antitumor immunity (author's transl)].
Kataoka T
Seikagaku; 1982; 54(3):139-50. PubMed ID: 6212615
[No Abstract] [Full Text] [Related]
20. Tremelimumab (anti-CTLA4) mediates immune responses mainly by direct activation of T effector cells rather than by affecting T regulatory cells.
Khan S; Burt DJ; Ralph C; Thistlethwaite FC; Hawkins RE; Elkord E
Clin Immunol; 2011 Jan; 138(1):85-96. PubMed ID: 21056008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
